Jonathan Herskovitz

3.2k total citations · 2 hit papers
24 papers, 2.2k citations indexed

About

Jonathan Herskovitz is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Jonathan Herskovitz has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Jonathan Herskovitz's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jonathan Herskovitz is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jonathan Herskovitz collaborates with scholars based in United States, India and China. Jonathan Herskovitz's co-authors include Howard E. Gendelman, Bhavesh D. Kevadiya, Jatin Machhi, Heidi Elsaesser, Mahmudul Hasan, Elizabeth Wilson, David G. Brooks, Wilson R. Blomberg, Christopher L. Karp and Jane C. Deng and has published in prestigious journals such as Science, Nature Materials and PLoS ONE.

In The Last Decade

Jonathan Herskovitz

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostics for SARS-CoV-2 infections

2021 585 citations Bhavesh D. Kevadiya, Jatin Machhi et al. Nature Materials profile →
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

2013 548 citations Elizabeth Wilson, Douglas H. Yamada et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Herskovitz United States	15	792	659	590	354	241	24	2.2k
Ling‐Pei Ho United Kingdom	32	461 0.6×	1.1k 1.6×	675 1.1×	145 0.4×	181 0.8×	74	3.5k
James J. Kobie United States	26	485 0.6×	1.0k 1.6×	516 0.9×	64 0.2×	399 1.7×	65	2.1k
Jorge A. Tavel United States	21	440 0.6×	393 0.6×	632 1.1×	149 0.4×	179 0.7×	43	2.5k
Jian Zheng United States	34	1.4k 1.7×	1.8k 2.8×	645 1.1×	96 0.3×	393 1.6×	105	3.8k
Yong Feng China	20	1.5k 1.9×	226 0.3×	703 1.2×	119 0.3×	238 1.0×	63	2.5k
Javid Sadri Nahand Iran	38	380 0.5×	478 0.7×	2.3k 3.9×	204 0.6×	459 1.9×	96	3.8k
Yingying Guo China	10	2.8k 3.5×	365 0.6×	1.1k 1.8×	160 0.5×	219 0.9×	20	3.9k
Joachim Seybold Germany	32	477 0.6×	817 1.2×	1.0k 1.8×	139 0.4×	241 1.0×	80	3.1k
Zanxian Xia China	25	1.7k 2.1×	628 1.0×	1.5k 2.5×	137 0.4×	442 1.8×	58	3.7k
Lei Li China	30	589 0.7×	553 0.8×	974 1.7×	82 0.2×	179 0.7×	192	2.9k

Countries citing papers authored by Jonathan Herskovitz

Since Specialization

Citations

This map shows the geographic impact of Jonathan Herskovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Herskovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Herskovitz more than expected).

Fields of papers citing papers by Jonathan Herskovitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Herskovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Herskovitz. The network helps show where Jonathan Herskovitz may publish in the future.

Co-authorship network of co-authors of Jonathan Herskovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Herskovitz. A scholar is included among the top collaborators of Jonathan Herskovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Herskovitz. Jonathan Herskovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zúñiga, Luis, et al.. (2024). S3676 Parasite Sufficiency Anemia: A Mysterious Cause of Iron Deficiency Anemia. The American Journal of Gastroenterology. 119(10S). S2421–S2421.

Herskovitz, Jonathan, et al.. (2024). S5087 Chicken Pox of the Gut in a Patient With Advanced HIV. The American Journal of Gastroenterology. 119(10S). S3195–S3196.

Wiley, Zanthia, et al.. (2023). Demographic representation among speakers at the Society for Healthcare Epidemiology of America (SHEA) spring conferences. Infection Control and Hospital Epidemiology. 45(4). 422–428. 1 indexed citations

Herskovitz, Jonathan, et al.. (2023). Rare Streptococcus intermedius Central Nervous System Septic Emboli: A Case Report and Review of Literature. Graduate Medical Education Research Journal. 5(2).

Herskovitz, Jonathan, Mahmudul Hasan, Milankumar Patel, Bhavesh D. Kevadiya, & Howard E. Gendelman. (2022). Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy. Methods in molecular biology. 2407. 429–445. 3 indexed citations

Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Pharmacotherapeutics of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 16(1). 12–37. 5 indexed citations

Kevadiya, Bhavesh D., Jatin Machhi, Jonathan Herskovitz, et al.. (2021). Diagnostics for SARS-CoV-2 infections. Nature Materials. 20(5). 593–605. 585 indexed citations breakdown →

Machhi, Jatin, Pravin Yeapuri, Yaman Lu, et al.. (2021). CD4+ effector T cells accelerate Alzheimer’s disease in mice. Journal of Neuroinflammation. 18(1). 272–272. 96 indexed citations

Herskovitz, Jonathan, Mahmudul Hasan, Milankumar Patel, et al.. (2021). CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination. EBioMedicine. 73. 103678–103678. 39 indexed citations

10.

Herskovitz, Jonathan, Mahmudul Hasan, Jatin Machhi, et al.. (2021). Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs. Nanotheranostics. 5(4). 417–430. 1 indexed citations

11.

Machhi, Jatin, Bhavesh D. Kevadiya, Jonathan Herskovitz, et al.. (2020). Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Molecular Neurodegeneration. 15(1). 32–32. 84 indexed citations

12.

Machhi, Jatin, Jonathan Herskovitz, Ahmed M. Senan, et al.. (2020). The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. Journal of Neuroimmune Pharmacology. 15(3). 359–386. 406 indexed citations

13.

Mukadam, Insiya, Jatin Machhi, Jonathan Herskovitz, et al.. (2019). Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking. Biomaterials. 231. 119669–119669. 22 indexed citations

14.

Hilaire, James R., Aditya N. Bade, Brady Sillman, et al.. (2019). Creation of a long-acting rilpivirine prodrug nanoformulation. Journal of Controlled Release. 311-312. 201–211. 21 indexed citations

15.

Smith, Nathan, Aditya N. Bade, Dhruvkumar Soni, et al.. (2019). A long acting nanoformulated lamivudine ProTide. Biomaterials. 223. 119476–119476. 28 indexed citations

16.

Kevadiya, Bhavesh D., Insiya Mukadam, James R. Hilaire, et al.. (2019). Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues. Theranostics. 10(2). 630–656. 26 indexed citations

17.

Herskovitz, Jonathan & Howard E. Gendelman. (2018). HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication. Journal of Neuroimmune Pharmacology. 14(1). 52–67. 33 indexed citations

18.

Cunningham, Cameron R., Ameya S. Champhekar, Michael V. Tullius, et al.. (2016). Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathogens. 12(1). e1005356–e1005356. 54 indexed citations

19.

Joubert, Marisa K., Meghana Deshpande, Jane Yang, et al.. (2016). Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics. PLoS ONE. 11(8). e0159328–e0159328. 90 indexed citations

20.

Wilson, Elizabeth, Douglas H. Yamada, Heidi Elsaesser, et al.. (2013). Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection. Science. 340(6129). 202–207. 548 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact